The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention.
Publication/Presentation Date
11-13-2012
Abstract
Noncardiac surgery (NCS) may be required within the first year after percutaneous coronary intervention (PCI) in approximately 4% of patients and is the second most common reason for premature discontinuation of antiplatelet therapy (APT),which may, in turn, increase the risk of perioperative ischemic events, particularly stent thrombosis. Its continuation may increase the risk of perioperative bleeding. We review current information on the incidence of these events, particularly related to APT, describe potentially useful strategies to minimize the risks of adverse outcomes, and provide recommendations on APT use.
Volume
60
Issue
20
First Page
2005
Last Page
2016
ISSN
1558-3597
Published In/Presented At
Singla, S., Sachdeva, R., & Uretsky, B. F. (2012). The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention. Journal of the American College of Cardiology, 60(20), 2005–2016. https://doi.org/10.1016/j.jacc.2012.04.062
Disciplines
Medicine and Health Sciences
PubMedID
23083781
Department(s)
Department of Medicine, Cardiology Division
Document Type
Article